New combo for colorectal cancer shows promise but trial halted early
Disease control
Terminated
This phase 2 trial tested a new drug combination (NUFIRI-bev) against the standard treatment (FOLFIRI-bev) in 171 people with metastatic colorectal cancer that had already been treated. The goal was to see if the new combo could delay cancer growth better than the standard. Howev…
Phase: PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Jun 26, 2026 15:54 UTC